These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8992996)

  • 1. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
    Feldmesser M; Casadevall A
    J Immunol; 1997 Jan; 158(2):790-9. PubMed ID: 8992996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J; Kozel TR; Casadevall A
    J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J; Feldmesser M; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1398-405. PubMed ID: 7492075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
    Mukherjee J; Zuckier LS; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1994 Mar; 38(3):580-7. PubMed ID: 8203858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody.
    Yuan R; Casadevall A; Spira G; Scharff MD
    J Immunol; 1995 Feb; 154(4):1810-6. PubMed ID: 7836766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
    Maitta RW; Datta K; Pirofski LA
    Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3353-9. PubMed ID: 7642262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W; Cherniak R; Casadevall A
    Infect Immun; 1999 Jun; 67(6):3096-107. PubMed ID: 10338526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
    Parra C; González JM; Castañeda E; Fiorentino S
    Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production.
    Kawakami K; Qureshi MH; Zhang T; Okamura H; Kurimoto M; Saito A
    J Immunol; 1997 Dec; 159(11):5528-34. PubMed ID: 9548493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.
    Curtis JL; Huffnagle GB; Chen GH; Warnock ML; Gyetko MR; McDonald RA; Scott PJ; Toews GB
    Lab Invest; 1994 Jul; 71(1):113-26. PubMed ID: 8041111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M; Kress Y; Casadevall A
    J Infect Dis; 1998 Jun; 177(6):1639-46. PubMed ID: 9607844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA
    Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
    Mukherjee J; Pirofski LA; Scharff MD; Casadevall A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3636-40. PubMed ID: 8475112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
    Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.
    Garcia-Hermoso D; Dromer F; Janbon G
    Infect Immun; 2004 Jun; 72(6):3359-65. PubMed ID: 15155641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcus neoformans infection can elicit protective antibodies in mice.
    Mukherjee J; Scharff MD; Casadevall A
    Can J Microbiol; 1994 Oct; 40(10):888-92. PubMed ID: 8000967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.